US Patent Issued to RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL on April 21 for "Materials and methods for the treatment of disorders associated with the IRF2BPL gene" (Ohio Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,846, issued on April 21, was assigned to RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL (Columbus, Ohio).

"Materials and methods for the treatment of disorders associated with the IRF2BPL gene" was invented by Nicolas Sebastien Wein (Columbus, Ohio) and Kathrin Christine Meyer (Columbus, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides gene therapy vectors, such as adeno-associated virus (AAV), designed for treatment of an Interferon regulatory factor 2 binding protein like (IRF2BPL) disorder."

The patent was filed on Oct. 19, 2020, under Application No. 17/769,933.

*For further information, including images, char...